术前使用5-羟色胺类抗抑郁药与鼻整形术后并发症增加相关:倾向性评分匹配分析
本研究基于TriNetX全球协作网络进行回顾性队列分析,纳入年龄>18岁接受鼻整形手术的患者,分为术前使用5-羟色胺类抗抑郁药组和无使用史组,经1:1倾向性评分匹配后每组4917例。结果显示,使用5-羟色胺类抗抑郁药的患者在术后30天内再入院、阿片类药物使用和出血/血肿风险显著增加,且这些风险持续至术后60天和90天;术后1年手术翻修率两组相当。
要点
- 术前使用5-羟色胺类抗抑郁药与鼻整形术后30天内再入院、阿片使用及出血/血肿风险增加相关。
- 上述短期并发症风险在术后60天和90天仍持续存在。
- 术后1年手术翻修率在两组间无显著差异。
核心结论
- 术前使用5-羟色胺类抗抑郁药与鼻整形术后短期并发症风险增加相关。
研究设计与样本
- 回顾性队列分析,使用TriNetX全球协作网络数据,纳入年龄>18岁接受鼻整形手术的患者,分为术前有5-羟色胺类抗抑郁药使用记录组和无使用史组,经1:1倾向性评分匹配后每组4917例。
主要发现
- 术后30天内,5-羟色胺类抗抑郁药组再入院风险显著增加(RR 1.793;P = .01)。
- 术后30天内,5-羟色胺类抗抑郁药组阿片类药物使用风险显著增加(RR 1.361;P < .0001)。
- 术后30天内,5-羟色胺类抗抑郁药组出血/血肿风险显著增加(RR 1.596;P = .005)。
- 上述风险在术后60天和90天持续存在。
- 术后1年手术翻修率两组相当。
临床怎么用
- 对拟行鼻整形的患者,术前应评估5-羟色胺类抗抑郁药使用情况,并告知其短期并发症风险可能增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rhinoplasty is a common facial aesthetic procedure, but a high proportion of candidates for rhinoplasty present with anxiety and depressive disorders. Serotonergic antidepressants are widely used to manage these disorders, and recent reports linking these medications to increased postoperative complications suggest that it is important to assess whether their use carries a higher risk of complications following rhinoplasty. OBJECTIVES: The aim of this study was to evaluate the association between preoperative serotonergic antidepressant use and the incidence of postoperative complications following rhinoplasty. METHODS: A retrospective cohort analysis was conducted using the TriNetX Global Collaborative Network. Patients aged >18 years who had undergone rhinoplasty were divided into 2 groups: those who had documented serotonergic antidepressant use prior to surgery; and those with no history of serotonergic antidepressant use. Propensity score matching was applied to balance demographic and clinical variables. Primary outcomes included postoperative complications at 3 time intervals: 30 days, 60 days, and 90 days. Secondary outcomes included long-term complications after 1 year. RESULTS: After 1:1 propensity score matching, each cohort consisted of 4917 patients. Within 30 days following rhinoplasty, patients in the serotonergic cohort had a significantly increased risk of readmission (relative risk [RR], 1.793; P = .01), opioid use (RR, 1.361; P < .0001), and bleeding/hematoma rates (RR, 1.596; P = .005) compared with the control cohort. These risks persisted at 60 and 90 days postsurgery. For long-term outcomes, comparable rates of surgical revision rates were noted after 1 year. CONCLUSIONS: Serotonergic antidepressant use is associated with increased risk for short-term postoperative complications following rhinoplasty surgery. LEVEL OF EVIDENCE: 3 (THERAPEUTIC): For image description, please refer to the figure legend and surrounding text.
引用
- Zontag N, Skorochod R, Wolf Y, et al. Preoperative Serotonin Antidepressants Are Associated With Increased Postoperative Complications Following Rhinoplasty: A Propensity Score-Matched Analysis. Aesthet Surg J. 2026. PMID: 41672725. doi:10.1093/asj/sjag043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。